ABVC BioPharma, Inc. Common Stock (ABVC)

Price$1.36

Value ScoreD

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-62.92%

Price vs S&P 500 (4W)31.92%

VGM Score46.92

Market Capitalization$36.66M

All Metrics

Book Value / Share (Quarterly)$0.42

P/TBV (Annual)4.71x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)12.28%

Cash Flow / Share (Quarterly)$-0.13

Price vs S&P 500 (YTD)-44.74%

Gross Margin (TTM)0.25%

Net Profit Margin (TTM)-227.24%

EPS (TTM)$-0.42

10-Day Avg Trading Volume0.14M

EPS Excl Extra (TTM)$-0.42

Revenue Growth (5Y)-6.15%

EPS (Annual)$-0.39

ROI (Annual)-62.44%

Gross Margin (Annual)99.85%

Net Profit Margin (5Y Avg)-2674.08%

Cash / Share (Quarterly)$0.01

Revenue Growth QoQ (YoY)104.47%

ROA (Last FY)-37.55%

Revenue Growth TTM (YoY)56.56%

EBITD / Share (TTM)$-0.39

ROE (5Y Avg)-329.42%

Operating Margin (TTM)-256.03%

Cash Flow / Share (Annual)$-0.12

P/B Ratio3.40x

P/B Ratio (Quarterly)2.29x

Net Income / Employee (Annual)$-416,200

EV / Revenue (TTM)46.88x

Net Interest Coverage (TTM)-5.32x

ROA (TTM)-48.17%

EPS Incl Extra (Annual)$-0.39

Current Ratio (Annual)0.41x

Quick Ratio (Quarterly)0.07x

3-Month Avg Trading Volume0.09M

52-Week Price Return0.71%

Revenue / Employee (TTM)$41,900

Tangible BV / Share (Quarterly)$0.34

P/S Ratio (Annual)71.94x

Asset Turnover (Annual)0.07x

52-Week High$5.48

Operating Margin (5Y Avg)-2421.44%

EPS Excl Extra (Annual)$-0.39

26-Week Price Return-46.99%

Quick Ratio (Annual)0.35x

13-Week Price Return9.30%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)0.12x

Enterprise Value$37.41M

Revenue / Share Growth (5Y)-35.78%

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-20.65%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)19.33x

Pretax Margin (Annual)-1053.71%

Cash / Share (Annual)$0.03

3-Month Return Std Dev95.14%

Gross Margin (5Y Avg)52.97%

Net Income / Employee (TTM)$-495,900

ROE (Last FY)-71.17%

Net Interest Coverage (Annual)-7.35x

EPS Basic Excl Extra (Annual)$-0.39

P/FCF (TTM)215.65x

Receivables Turnover (TTM)85.00x

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$-0.42

Receivables Turnover (Annual)85.00x

ROI (TTM)-82.74%

P/S Ratio (TTM)45.95x

Pretax Margin (5Y Avg)-2656.65%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.94

Forward P/E1.06x

Price vs S&P 500 (52W)-27.49%

Year-to-Date Return-33.80%

5-Day Price Return23.68%

EPS Normalized (Annual)$-0.39

ROA (5Y Avg)-92.58%

Net Profit Margin (Annual)-962.12%

Month-to-Date Return36.89%

Cash Flow / Share (TTM)$-3.45

EBITD / Share (Annual)$-0.35

Operating Margin (Annual)-873.18%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-181.95%

LT Debt / Equity (Quarterly)0.18x

EPS Basic Excl Extra (TTM)$-0.42

P/TBV (Quarterly)247.13x

P/B Ratio (Annual)4.66x

Inventory Turnover (TTM)19.33x

Pretax Margin (TTM)-244.89%

Book Value / Share (Annual)$0.44

Price vs S&P 500 (13W)-0.44%

Beta0.57x

P/FCF (Annual)1222.02x

Revenue / Share (TTM)$0.03

ROE (TTM)-92.02%

52-Week Low$0.88

vGradeD

gGradeB

mGradeC

vgmGradeC

Show chart for

Analyst Recommendations

Jul 2023

Aug 2023

Sep 2023

Oct 2023

2.17

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
ABVCABVC BioPharma, Inc. Common Stock	D	B	C	$1.36
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

ABVC BioPharma is a clinical-stage biopharmaceutical company developing a pipeline of six drug candidates and a medical device based on botanically-derived therapeutics. The company focuses on proof-of-concept and Phase II clinical trials, leveraging proprietary technology to deliver high efficacy with low toxicity profiles.